Breaks Categories: News

FridayFeb 14, 2020 9:25 am

NetworkNewsBreaks – SinglePoint, Inc. (SING) CEO Discusses Hemp Cigarette Brand on MoneyTV with Donald Baillargeon

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint CEO Greg Lambrecht discussed the company’s ideal position to profit from its hemp cigarette brand as the price of hemp flower has decreased. “The price of hemp flower has really gone down. There's been so many farmers that have started…

Continue Reading

FridayFeb 14, 2020 9:00 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Inks Exclusive License Agreement with University of Pittsburgh for Diabetes Gene Therapy

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and other serious diseases, recently announced its entry into an exclusive license agreement with the University of Pittsburgh for a diabetes gene therapy that may have the potential to cure Type 1 and Type 2 diabetes, which together currently affect approximately 30.3 million people in the U.S., or 9% of the U.S. population. According to the update, Genprex’s licensed diabetes gene therapy technology is designed to reprogram alpha cells in the pancreas into beta-like cells, restoring their function, thereby replenishing insulin levels. “We are…

Continue Reading

ThursdayFeb 13, 2020 2:57 pm

NetworkNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) (OTCQB: TRXD) Announces Nasdaq Uplisting, Pricing of $5.2M Firm Commitment Public Offering, Effectiveness of Reverse Stock Split

Trxade Group (NASDAQ: MEDS) (OTCQB: TRXD), an integrated drug procurement, delivery and healthcare platform that enables price transparency and increased profit margins to healthcare buyers and sellers of pharmaceuticals, this morning announced that its common stock will today begin trading on the Nasdaq Capital Market under the new symbol ‘MEDS’. In connection with the company’s uplisting, Trxade’s common stock will cease trading on the OTCQB. In addition, Trxade Group also announced the pricing of a firm commitment public offering of 806,452 shares of its common stock at a price to the public of $6.50 per share. Trxade Group granted a…

Continue Reading

ThursdayFeb 13, 2020 1:35 pm

NetworkNewsBreaks – CloudCommerce, Inc. (CLWD) Announces Receipt of First Subscriptions in $20M Reg A+ Public Offering

CloudCommerce (OTC: CLWD), a leading provider of digital advertising solutions, today announced receipt of its first subscriptions in its $20 million Reg A+ Public Offering. According to the update, CloudCommerce is offering up to $20,000,000 of preferred stock, at a price of $25.00 per share, to qualified investors in a Reg A+ public offering. The preferred stock will pay a 10%, annual dividend, with payments made monthly. CloudCommerce will seek to have a market maker file an application with FINRA in order to quote the Preferred Stock on the OTC market. To view the full press release, visit http://nnw.fm/CepJ8 About…

Continue Reading

ThursdayFeb 13, 2020 1:29 pm

NetworkNewsBreaks – SinglePoint, Inc. (SING) Provides Update on Bullish Outlook for Upcoming Solar+ Decade and the Future of Energy in America

SinglePoint (OTCQB: SING) today provided an update on the bullish outlook for 2020 and beyond for solar and renewable energy and its acquisition of Direct Solar America, a unique and scalable national solar energy brokerage focused on finding and arranging installation of the best available solar energy system for any residential home or commercial building. According to the update, revenues and coverage has expanded in a little over six months since the acquisition, firmly establishing the company’s footprint in the solar sector, which is predicted to continue to grow throughout the next decade. National trade association of the U.S., Solar…

Continue Reading

ThursdayFeb 13, 2020 12:43 pm

NetworkNewsBreaks – Akoustis Technologies, Inc. (NASDAQ: AKTS) Featured in ROTH Equity Research Report

Akoustis Technologies (NASDAQ: AKTS) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “We regard AKTS as an emerging vendor of RF filters for the smartphone, WiFi, infrastructure and defense markets. AKTS’ revenue guidance reflects expectation for volume filter revenue ramp in the mid-to-late CY20 timeframe. However, AKTS remains comfortable that revenue growth and volume production ramp can be supported by multiple end market programs from several Tier-1 customers. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Akoustis Technologies, Inc. Akoustis(R) is a high-tech BAW…

Continue Reading

ThursdayFeb 13, 2020 12:38 pm

NetworkNewsBreaks – Fortress Biotech, Inc. (NASDAQ: FBIO) Featured in ROTH Equity Research Report

Fortress Biotech (NASDAQ: FBIO) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “This is a weekly update tracking prescriptions for FBIO's Ximino launch (extended release minocycline capsule for the treatment of acne). Total prescriptions decreased to 2,083 from 2,365 last week. Overall, we viewed this week's data as noise given the Martin Luther King Jr. holiday celebrated on January 20th. Maintain Buy rating with a price target of $4.00/share.” To request access to the full report, visit http://nnw.fm/DXCr3 About Fortress Biotech Fortress Biotech, Inc. (“Fortress”) is an innovative biopharmaceutical company that…

Continue Reading

ThursdayFeb 13, 2020 12:24 pm

NetworkNewsBreaks – Atomera, Inc. (NASDAQ: ATOM) Featured in ROTH Equity Research Report

Atomera (NASDAQ: ATOM) was featured in a recent Equity Research Report published by ROTH Capital Partners, LLC. The report reads, “We regard ATOM as a highly differentiated silicon enhancement IP vendor that is gaining traction with large semiconductor supply chain companies. We believe the company continues to make solid progress across its significant base of engagements. We expect ATOM to continue to convert additional engagements to licensing revenue over the next few quarters. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Atomera Inc. Atomera has developed Mears Silicon Technology(TM) ("MST"), which increases performance…

Continue Reading

ThursdayFeb 13, 2020 12:20 pm

NetworkNewsBreaks – aTyr Pharma, Inc. (NASDAQ: LIFE) Secures $18 Million in Underwritten Public Offering

aTyr Pharma (NASDAQ: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, has closed an underwritten public offering of 4,235,294 shares of its common stock. According to the update, the shares were each sold at the public offering price of $4.25, resulting in approximately $18 million in proceeds for aTyr Pharma. In addition, aTyr Pharma has granted the underwriters a 30-day option to purchase up to an additional 635,294 shares of common stock in connection with the public offering. ROTH Capital Partners acted as lead manager for the offering. To view…

Continue Reading

ThursdayFeb 13, 2020 11:43 am

NetworkNewsBreaks – InnerScope Hearing Technologies (INND) Announces Launch of Hearing and Tinnitus Dietary Supplements on Sears.com

InnerScope Hearing Technologies (OTC: INND), a manufacturer and Direct-to-Consumer ("DTC") distributor/retailer of FDA-registered hearing aids, personal sound amplifiers products, hearing related treatment therapies, doctor-formulated dietary hearing & tinnitus supplements, proprietary CBD oil for tinnitus and assorted ear & hearing aid related supplies (collectively "hearing product portfolio"), today announced the launch of its complete line of "Nutrition for the Ears" doctor-formulated dietary hearing and tinnitus supplements on Sears.com. According to the update, the supplement formulations are specifically designed with a proprietary blend of vitamins, minerals and nutrients that medical research indicated may slow the progression of age-related hearing loss and help…

Continue Reading